Vertaling van "human papillomavirus " (Frans → Nederlands) :

TERMINOLOGIE

papillomavirus bovin
bovien papillomavirus

papillomavirus humain 32
humaan papillomavirus 32

papillomavirus humain de type 4
humaan papillomavirus type 4

papillomavirus humain
humaan papillomavirus

papillomavirus équin
papillomavirus van paard

papillomavirus oral canin
oraal papillomavirus van hond

Genus papillomavirus bovin-like viruses
genus boviene papillomavirus-achtige virussen

papillomavirus humain de type 6
humaan papillomavirus type 6

papillomavirus humain de type 3
humaan papillomavirus type 3

papillomavirus humain de type 9
humaan papillomavirus type 9

IN-CONTEXT TRANSLATIONS

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005a; 14:1157-1164.
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by

Liste des abréviations utilisées BBV : Blood-borne virus CSS : Conseil Supérieur de la Santé Ea : entre autres HCV : Hepatitis C virus HBV : Hepatitis B virus HIV : Human immunodeficiency virus HPV : human papillomavirus OATA : Ornamental Aquatic Trade Association UFC : Unité formant colonie UV : Ultraviolet UVA : Ultraviolet A
Blood-borne virus Hoge Gezondheidsraad Hepatitis C-virus Hepatitis B-virus Human immunodeficiency virus human papillomavirus Ornamental Aquatic Trade Association Colony forming unit (Kolonievormende eenheid) Ultraviolet Ultraviolet A

- Taira AV, Neukermans CP, Sanders GD. Evaluating human papillomavirus vaccination
- Stanley M. Immune responses to human papillomavirus.

- Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364:1757- 1765.
- Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus

- Paavonen J, Jenkins D, Bosch FX, Naud P, Salméron J, C. Wheeler et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.
- Paavonen J, Jenkins D, Bosch FX, Naud P, Salméron J, C. Wheeler et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women : an interim analysis of a phase III double-blind, randomised controlled trial.

Beaucoup de pathogènes, y compris des champignons de type dermatophytes, levures et autres moisissures provoquant l’intertrigo interdigitale et/ou le tinea pedis (pied d’athlète) ainsi que les human papillomavirus (HPV) responsables des verrues vulgaires sont connus pour survivre sur des surfaces planes pendant des périodes prolongées.
Veel pathogenen met inbegrip van fungi van het type dermatofyten, gisten en andere schimmels die interdigitale intertrigo en/of tinea pedis (atletenvoet) veroorzaken en ook de humane papillomavirussen (HPV) verantwoordelijk voor gewone wratten, zijn bekend voor het langdurig overleven op vlakke oppervlakken.